Welcome to our dedicated page for McKesson SEC filings (Ticker: MCK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
McKesson Corporation filings document operating results, capital structure, financing arrangements, governance matters, and registered securities for the healthcare services and pharmaceutical distribution company. Its 8-K reports include quarterly and annual results, financial guidance, share repurchase authorizations, dividend-related disclosures, and Regulation FD materials connected to earnings communications.
McKesson's SEC records also cover material credit agreements, including revolving credit facilities and subsidiary senior secured facilities, as well as executive officer transition disclosures and related arrangements. The filing record identifies NYSE-listed common stock and debt securities, including notes due 2026 and 2029, and includes a Form 25 notice for removal from listing and registration of notes due 2025.
MCKESSON CORP senior vice president, controller and chief accounting officer Napoleon B. Rutledge Jr. reported an open-market sale of 133 shares of common stock at $764 per share. After this Form 4 transaction, he holds 632 shares directly. The sale was executed under a previously adopted Rule 10b5-1(c) trading plan dated March 2, 2026.
McKesson Corporation executive Thomas L. Rodgers reported open-market sales of company stock under a pre-arranged trading plan. He sold 699 shares of common stock at about $735.27 per share on one day and 123 shares at about $735.50 per share on the prior day, for a total of 822 shares sold. After these transactions, he directly holds 2,268 McKesson common shares. The filing notes the sales were made pursuant to a previously adopted Rule 10b5-1(c) plan, indicating the trades were scheduled in advance rather than timed discretionarily.
McKesson Corporation executive LeAnn B. Smith, EVP & Chief HR Officer, sold 1,810 shares of McKesson common stock in an open-market transaction on June 1, 2026 at $735.50 per share. The sale was made under a previously adopted Rule 10b5-1 trading plan dated June 8, 2025, indicating it was pre-scheduled. After this transaction, she directly owns 4,798 shares of McKesson common stock.
Thomas L. Rodgers reported proposed sales of Common Stock under Rule 144. The filing lists restricted stock vesting events of 167, 226, and 306 shares on 05/20/2026, 05/21/2026, and 05/23/2026, respectively. It also records recent sales of 2,388 shares for $1,817,482.92 on 05/26/2026 and 123 shares for $90,466.50 on 06/01/2026.
Cheung Kenny K reported acquisition or exercise transactions in this Form 4 filing.
McKesson Corporation EVP & CFO Kenny K. Cheung reported awards of restricted stock units that provide future rights to common shares as part of his compensation. He received 3,019 RSUs and a separate grant of 8,082 RSUs, each tied to McKesson common stock.
The footnote states these RSUs will vest in three equal installments on June 1, 2027, June 1, 2028, and June 1, 2029, creating a multi-year incentive for continued service and performance. The transactions do not reflect open-market purchases or sales.
MCKESSON CORP executive Kenny K. Cheung, EVP & CFO, filed an initial Form 3 ownership report. This filing identifies him as a reporting officer of the company and, in this case, shows no reported buy, sell, or other insider transactions in McKesson stock.
MCK-related Form 144 reports restricted stock vesting entries and an open-market sale. The excerpt lists restricted stock vesting of 29 shares on 05/20/2026, 40 shares on 05/21/2026, and 54 shares on 05/23/2026. It also shows a sale by Thomas L. Rodgers of 2,388 shares on 05/26/2026 for $1,817,482.92.
McKesson Corp. submitted a Form 144 notice related to proposed sales of Common Stock. The filing lists a broker, Fidelity Brokerage Services LLC, and records several Restricted Stock vesting events on 05/19/2026, 05/20/2026, 05/21/2026, and 05/23/2026 with share counts shown.
The excerpt includes numeric entries such as 1810, an amount shown as 1331255.00, and vesting quantities 1303, 140, 161, and 206. The filing is a notice of intent to sell by an affiliate; specific sale mechanics and timing are not detailed in the excerpt.
McKesson Corp executive Michele Lau, EVP and Chief Legal Officer, reported an open-market sale of common stock. Lau sold 3,550 shares at $761.09 per share, leaving 3,247 directly held shares after the transaction, plus 139.0253 shares held indirectly through the McKesson Corporation 401(k) Retirement Savings Plan.
The sale occurred on May 26, 2026 and was carried out as an open-market sale designated by transaction code “S”. A footnote states the sale was made pursuant to a previously adopted Rule 10b5-1(c) trading plan dated August 19, 2025, indicating it was pre-planned under SEC rules rather than a discretionary trade based on short-term market conditions.
McKesson Corp Chief Executive Officer Brian S. Tyler reported equity compensation activity involving restricted stock units and related tax withholding. On 2026-05-23, he exercised 4,579 Restricted Stock Units (RSUs) into 4,579 shares of Common Stock. To cover taxes on this RSU vesting, 1,831 shares of Common Stock were withheld, as noted in the footnotes, leaving the remainder as net shares received. Following these transactions, he held 27,774 shares of Common Stock directly and 215.7888 shares indirectly through the McKesson Corporation 401(k) Retirement Savings Plan. The filing also notes that the RSUs in this award vested in three equal installments on 5/23/2024, 5/23/2025 and 5/23/2026.